NIH-funded research R21 grant

How cells choose their EV neighbors and how to map it

Official title: Mechanisms of Cell Type-Specific EV Transfer

Funded at University of New Mexico Health Scis Ctr · NIH-11502652 · Data updated 2026-11-12

Researchers are testing a new method to understand how tiny particles called extracellular vesicles talk to specific cell types, which could reveal why some signals reach certain brain cells.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of New Mexico Health Scis Ctr
NIH-funded
Lab location1 site (Albuquerque, United States)
Project startSeptember 10, 2026
Project endAugust 31, 2028
Funding year2026
Award (this year)$409,925
NIH project number1R21NS153244-01
Project IDNIH-11502652 on NIH RePORTER

Who could benefit from this research

Could help

Not applicable for this grant as described; the study is basic science using human stem cells and cell models rather than enrolling patients.

Less likely to help

This project does not involve patient participation or testing in people.

What this research studies

This project uses a novel “EV-Trap” system to capture the fleeting interactions between extracellular vesicles and the surfaces of recipient cells. It combines directed differentiation of human stem cells, controlled EV uptake experiments, and proximity-based labeling to identify which proteins help EVs recognize and engage specific cell types. The team will then use bioinformatics and gene editing to confirm which ligands and receptors are critical for cell-type specific transfer. The work focuses on brain-related cell types to uncover fundamental biology that may inform future therapies.

Why it matters

Potential benefit: If successful, this research could provide a map of which proteins control EV targeting, potentially guiding safer and more precise future treatments that use EVs to deliver therapies to specific brain cells.

How similar studies have gone: Previous work suggests that EV-cell communication is nuanced, with some evidence for specific targeting, but the exact molecular players remain to be defined.

Where this research is happening

  • University of New Mexico Health Scis Ctr
    Albuquerque, United States
    Active

Researchers

  • Principal investigator: Weick, Jason P — University of New Mexico Health Scis Ctr
  • Study coordinator: Weick, Jason P

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.